Phase 2 Shigella Vaccine and Challenge

Clinical trial NCT04242264 · COMPLETED

Trial details

NCT number: NCT04242264
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Immunisation Shigella Infection

Start date: 2022-10-12
Primary completion: 2024-03-11
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.